Literature DB >> 21969607

Tyrosine phosphorylation of lactate dehydrogenase A is important for NADH/NAD(+) redox homeostasis in cancer cells.

Jun Fan1, Taro Hitosugi, Tae-Wook Chung, Jianxin Xie, Qingyuan Ge, Ting-Lei Gu, Roberto D Polakiewicz, Georgia Z Chen, Titus J Boggon, Sagar Lonial, Fadlo R Khuri, Sumin Kang, Jing Chen.   

Abstract

The Warburg effect describes an increase in aerobic glycolysis and enhanced lactate production in cancer cells. Lactate dehydrogenase A (LDH-A) regulates the last step of glycolysis that generates lactate and permits the regeneration of NAD(+). LDH-A gene expression is believed to be upregulated by both HIF and Myc in cancer cells to achieve increased lactate production. However, how oncogenic signals activate LDH-A to regulate cancer cell metabolism remains unclear. We found that the oncogenic receptor tyrosine kinase FGFR1 directly phosphorylates LDH-A. Phosphorylation at Y10 and Y83 enhances LDH-A activity by enhancing the formation of active, tetrameric LDH-A and the binding of LDH-A substrate NADH, respectively. Moreover, Y10 phosphorylation of LDH-A is common in diverse human cancer cells, which correlates with activation of multiple oncogenic tyrosine kinases. Interestingly, cancer cells with stable knockdown of endogenous LDH-A and rescue expression of a catalytic hypomorph LDH-A mutant, Y10F, demonstrate increased respiration through mitochondrial complex I to sustain glycolysis by providing NAD(+). However, such a compensatory increase in mitochondrial respiration in Y10F cells is insufficient to fully sustain glycolysis. Y10 rescue cells show decreased cell proliferation and ATP levels under hypoxia and reduced tumor growth in xenograft nude mice. Our findings suggest that tyrosine phosphorylation enhances LDH-A enzyme activity to promote the Warburg effect and tumor growth by regulating the NADH/NAD(+) redox homeostasis, representing an acute molecular mechanism underlying the enhanced lactate production in cancer cells.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21969607      PMCID: PMC3233034          DOI: 10.1128/MCB.06120-11

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  30 in total

Review 1.  The hallmarks of cancer.

Authors:  D Hanahan; R A Weinberg
Journal:  Cell       Date:  2000-01-07       Impact factor: 41.582

2.  Effects of N-terminal deletion mutation on rabbit muscle lactate dehydrogenase.

Authors:  Yanbin Zheng; Shuyuan Guo; Zhi Guo; Xicheng Wang
Journal:  Biochemistry (Mosc)       Date:  2004-04       Impact factor: 2.487

3.  Phosphotyrosine-containing lactate dehydrogenase is restricted to the nuclei of PC12 pheochromocytoma cells.

Authors:  X H Zhong; B D Howard
Journal:  Mol Cell Biol       Date:  1990-02       Impact factor: 4.272

4.  Dimers of porcine skeletal muscle lactate dehydrogenase produced by limited proteolysis during reassociation are enzymatically active in the presence of stabilizing salt.

Authors:  R Girg; R Jaenicke; R Rudolph
Journal:  Biochem Int       Date:  1983-10

5.  Growth factors can influence cell growth and survival through effects on glucose metabolism.

Authors:  M G Vander Heiden; D R Plas; J C Rathmell; C J Fox; M H Harris; C B Thompson
Journal:  Mol Cell Biol       Date:  2001-09       Impact factor: 4.272

6.  Interaction of Cibacron Blue 3GA and Remazol Brilliant Blue R with the nucleotide binding site of lactate dehydrogenase and (Na+ + K+)-ATPase.

Authors:  V Durisová; A Vrbanová; A Ziegelhöffer; A Breier
Journal:  Gen Physiol Biophys       Date:  1990-10       Impact factor: 1.512

7.  Aberrant expression of type I fibroblast growth factor receptor in human pancreatic adenocarcinomas.

Authors:  M S Kobrin; Y Yamanaka; H Friess; M E Lopez; M Korc
Journal:  Cancer Res       Date:  1993-10-15       Impact factor: 12.701

8.  Lactate dehydrogenase M-subunit deficiency: a new type of hereditary exertional myopathy.

Authors:  T Kanno; K Sudo; M Maekawa; Y Nishimura; M Ukita; K Fukutake
Journal:  Clin Chim Acta       Date:  1988-03-31       Impact factor: 3.786

Review 9.  Hallmarks of cancer: the next generation.

Authors:  Douglas Hanahan; Robert A Weinberg
Journal:  Cell       Date:  2011-03-04       Impact factor: 41.582

10.  Expression of basic fibroblast growth factor, FGFR1 and FGFR2 in normal and malignant human breast, and comparison with other normal tissues.

Authors:  Y A Luqmani; M Graham; R C Coombes
Journal:  Br J Cancer       Date:  1992-08       Impact factor: 7.640

View more
  84 in total

1.  Low glucose stress decreases cellular NADH and mitochondrial ATP in colonic epithelial cancer cells: Influence of mitochondrial substrates.

Authors:  Magdalena L Circu; Ronald E Maloney; Tak Yee Aw
Journal:  Chem Biol Interact       Date:  2017-01-10       Impact factor: 5.192

2.  Purification and characterization of a urea sensitive lactate dehydrogenase from the liver of the African clawed frog, Xenopus laevis.

Authors:  Barbara A Katzenback; Neal J Dawson; Kenneth B Storey
Journal:  J Comp Physiol B       Date:  2014-03-21       Impact factor: 2.200

3.  Therapeutic arginine starvation in ASS1-deficient cancers inhibits the Warburg effect.

Authors:  Jeff C Kremer; Brian A Van Tine
Journal:  Mol Cell Oncol       Date:  2017-03-01

4.  Skeletal muscle PGC-1α controls whole-body lactate homeostasis through estrogen-related receptor α-dependent activation of LDH B and repression of LDH A.

Authors:  Serge Summermatter; Gesa Santos; Joaquín Pérez-Schindler; Christoph Handschin
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-06       Impact factor: 11.205

5.  Sorbitol dehydrogenase overexpression and other aspects of dysregulated protein expression in human precancerous colorectal neoplasms: a quantitative proteomics study.

Authors:  Anuli Uzozie; Paolo Nanni; Teresa Staiano; Jonas Grossmann; Simon Barkow-Oesterreicher; Jerry W Shay; Amit Tiwari; Federico Buffoli; Endre Laczko; Giancarlo Marra
Journal:  Mol Cell Proteomics       Date:  2014-02-24       Impact factor: 5.911

6.  Glycolytic reliance promotes anabolism in photoreceptors.

Authors:  Yashodhan Chinchore; Tedi Begaj; David Wu; Eugene Drokhlyansky; Constance L Cepko
Journal:  Elife       Date:  2017-06-09       Impact factor: 8.140

Review 7.  Cancer metabolism: what we can learn from proteomic analysis by mass spectrometry.

Authors:  Weidong Zhou; Lance A Liotta; Emanuel F Petricoin
Journal:  Cancer Genomics Proteomics       Date:  2012-11       Impact factor: 4.069

8.  Phosphorylation-mediated activation of LDHA promotes cancer cell invasion and tumour metastasis.

Authors:  L Jin; J Chun; C Pan; G N Alesi; D Li; K R Magliocca; Y Kang; Z G Chen; D M Shin; F R Khuri; J Fan; S Kang
Journal:  Oncogene       Date:  2017-02-20       Impact factor: 9.867

Review 9.  Metabolism and immunity in breast cancer.

Authors:  Deyu Zhang; Xiaojie Xu; Qinong Ye
Journal:  Front Med       Date:  2020-10-19       Impact factor: 4.592

10.  Tyr-94 phosphorylation inhibits pyruvate dehydrogenase phosphatase 1 and promotes tumor growth.

Authors:  Changliang Shan; Hee-Bum Kang; Shannon Elf; Jianxin Xie; Ting-Lei Gu; Mike Aguiar; Scott Lonning; Taro Hitosugi; Tae-Wook Chung; Martha Arellano; Hanna J Khoury; Dong M Shin; Fadlo R Khuri; Titus J Boggon; Jun Fan
Journal:  J Biol Chem       Date:  2014-06-24       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.